The incubation mixtures were loaded onto the native gel (10%) that was run as explained inFig. small C-terminal fragment (residues 94100) in answer. Neither of these fragments associates with HLA-A*1101 as shown by a native gel band-shift assay. In contrast, the N-terminal 193 residues of Ad2 E3-19K exhibited the same binding affinity to HLA-A*1101 as E3-19K. Using a site-directed mutational analysis and circulation cytometry, we show that Tyr93, but not Tyr88, critically modulates the cell-surface expression of MHC class I molecules. Taken together, these results show that the sequence comprising residues 89 to 93 (M89SKQY93), and in particular Tyr93, in the conserved region of E3-19K is critical for its immunomodulatory function. Residues 89 to 93 likely form a linker or loop in E3-19K. Overall, our data provide novel insights into the structure of E3-19K and identify important determinants for association with and ER-retention of its cellular target protein. This knowledge is usually important for our understanding of the molecular basis of Ad pathogenesis. Keywords:E3-19K, Adenovirus, prolonged viruses, immunomodulatory proteins, immune evasion mechanisms, MHC class I molecules, and antigen presentation == 1. Introduction == MHC class I molecules present viral peptides to CTLs as part of a process that activates the immune system to lyse infected cells. In turn, viruses have developed mechanisms to suppress the surface presentation of viral peptides on infected cells. It is now well established that this viral proteins involved in these mechanisms suppress cellular immune responses by interfering with important steps of the class I antigen presentation pathway (Hansen and Bouvier, 2009). Ads cause acute and prolonged infections of the respiratory, gastrointestinal, and urinary tracts and eyes (Horwitz, 1990). There are at least 51 human Ad serotypes (Ad1 to Ad51) classified into six subgroups (A to F) (Green et al.,1979;Wadell, CD123 1984). The genome of Ad of all subgroups, with the exception of subgroups A and F, codes for an E3-19K immunomodulatory protein in theearly 3(E3)transcription unit (Pbo et al., 1986a). E3-19K abolishes the presentation of viral peptides by newly synthesized MHC class I molecules (Burgert and Kvist, 1985,1987;Cox et al., 1990;Kvist et al., 1978) and, consequently, suppresses the activity of Ad-specific CTLs (Andersson et al., 1987;Burgert et al., 1987;Flomenberg et al., 1996;Rawle et al., 1989).In vivodata strongly support a role for E3-19K in Ad infections (Ginsberg et al., 1989); lungs of cotton rats infected with a mutant Ad made up of a deletion of the E3-19K gene caused a more severe immunopathology than lungs infected with wild-type Ad. It was suggested that the absence of E3-19K in the mutant computer virus activated Ad-specific CTLs as part of the inflammatory response to viral contamination (Ginsberg et al., 1989). E3-19K is usually a type I transmembrane glycoprotein that comprises a N-terminus ER-lumenal domain name and a short C-terminus cytosolic tail. The ER-lumenal domain name of E3-19K binds directly to the ER-lumenal domain name of MHC class I molecules (Beier et al., 1994;Burgert and Kvist, 1987;Feuerbach et al., 1994;Flomenberg et al., 1994;Gabathuler et al., 1990;Herminston et al., 1993) and the dilysine motif in the cytosolic tail of E3-19K provides the transmission for localization in the ER (Burgert and Kvist, 1987;Cox et al., 1991;Pbo et al., 1987). Based on sequence Bipenquinate comparisons of E3-19K proteins of serotypes from different subgroups, the ER-lumenal domain name has been subdivided into three unique regions with loosely defined boundaries (Flomenberg et al., 1992;Herminston et al., 1993): (1) residues 1 to ~78/81 are rather variable between E3-19K proteins of different subgroups; (2) residues ~79/82 to 98 are rather conserved between E3-19K proteins of different subgroups; and (3) residues 99 to 107 link the ER-lumenal domain name to the transmembrane domain name. To date, our knowledge of how the variable and conserved regions of E3-19K interact with MHC class I molecules is usually unclear. Several residues have, however, been recognized to be crucial in modulating E3-19K function: in the variable region, Trp52in Ad2 E3-19K (Sester et al., 2010) and in the conserved region, Glu104, Asp107, Met110, and Lys114in Ad35 E3-19K (Flomenberg et al., 1992) (equivalent to positions 81, 84, 87, and 91 in Ad2 E3-19K) and Met87and Trp96in Ad2 E3-19K (Sester et al., 2010). Evidence has also been provided that E3-19K targets the 1- and 2-domains (peptide-binding groove) of MHC class I molecules (Beier et al., 1994;Feuerbach et al., 1994;Flomenberg et Bipenquinate al., 1994). Consistent with this, we showed previously that MHC residue 56 (located at the N-terminal end of the 1-helix) is usually part of the E3-19K/MHC I binding interface (Liu et al., 2007). To date, even though molecular basis of Ad pathogenesis is not well understood, it is thought that the E3-19K/MHC Bipenquinate I association plays an important role in.